KR950702203A - 콜레스테롤과잉혈증 치료용 스테로이드성 글리코사이드(steroldal glycosides for treating hypercholesterolemia) - Google Patents

콜레스테롤과잉혈증 치료용 스테로이드성 글리코사이드(steroldal glycosides for treating hypercholesterolemia)

Info

Publication number
KR950702203A
KR950702203A KR1019940704728A KR19940704728A KR950702203A KR 950702203 A KR950702203 A KR 950702203A KR 1019940704728 A KR1019940704728 A KR 1019940704728A KR 19940704728 A KR19940704728 A KR 19940704728A KR 950702203 A KR950702203 A KR 950702203A
Authority
KR
South Korea
Prior art keywords
steroldal
glycosides
treating hypercholesterolemia
hypercholesterolemia
treating
Prior art date
Application number
KR1019940704728A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950702203A publication Critical patent/KR950702203A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
KR1019940704728A 1992-06-26 1994-12-24 콜레스테롤과잉혈증 치료용 스테로이드성 글리코사이드(steroldal glycosides for treating hypercholesterolemia) KR950702203A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90491492A 1992-06-26 1992-06-26
PCT/US1993/004092 WO1994000480A1 (en) 1992-06-26 1993-05-06 Steroidal glycosides for treating hypercholesterolemia

Publications (1)

Publication Number Publication Date
KR950702203A true KR950702203A (ko) 1995-06-19

Family

ID=25419965

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940704728A KR950702203A (ko) 1992-06-26 1994-12-24 콜레스테롤과잉혈증 치료용 스테로이드성 글리코사이드(steroldal glycosides for treating hypercholesterolemia)

Country Status (19)

Country Link
US (2) US5629295A (ko)
EP (4) EP0796864A2 (ko)
JP (2) JPH07504921A (ko)
KR (1) KR950702203A (ko)
CN (1) CN1085561A (ko)
AP (1) AP489A (ko)
AU (1) AU4226593A (ko)
BG (1) BG99261A (ko)
BR (1) BR9306619A (ko)
CA (1) CA2139104A1 (ko)
CZ (1) CZ331094A3 (ko)
HR (1) HRP930994A2 (ko)
IL (1) IL106055A0 (ko)
MX (1) MX9303826A (ko)
OA (1) OA10121A (ko)
RU (1) RU94046294A (ko)
SK (1) SK158394A3 (ko)
WO (1) WO1994000480A1 (ko)
YU (1) YU44793A (ko)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0647233A1 (en) * 1992-06-26 1995-04-12 Pfizer Inc. Steroidal beta-o-cellobioside heptaalkanoate process
CZ280195A3 (en) * 1993-04-28 1996-02-14 Pfizer Crystalline spirostanyl glycoside, monohydrate thereof, pharmaceutical composition based thereon and process for preparing crystalline steroidal glycoside
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
ES2074006B1 (es) * 1993-07-05 1996-03-16 Pfizer Glicosidos esteroidales para tratar hipercolesterolemia.
FI96243C (fi) * 1993-10-26 1996-05-27 Ilmari Paakkinen Menetelmä ja laite rakeisten maamassojen ominaisuuksien mittaamiseksi
EP0737202A1 (en) * 1993-12-28 1996-10-16 Pfizer Inc. Hypocholesterolemic agents
AU7948494A (en) * 1993-12-28 1995-07-17 Pfizer Inc. Steroidal glycosides
FR2722690B1 (fr) * 1994-07-21 1996-10-25 Univ Montpellier Ii Compositions de saponines et/ou de leurs formes aglycones et leurs applications comme medicaments
PL318937A1 (en) * 1994-08-30 1997-07-21 Pfizer Spirostanyloglycoside crystals
CA2200436A1 (en) * 1994-09-20 1996-04-04 Pfizer Inc. Combination therapy for hypercholesterolemia
US6150336A (en) * 1995-05-29 2000-11-21 Pfizer Inc. Steroidal glycosides
US5698527A (en) * 1995-08-08 1997-12-16 Merck & Co., Inc. Steroidal glycosides as antihyperlipidemic agents
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
DE69929177T2 (de) * 1998-03-26 2006-08-24 Phytopharm Plc, Godmanchester Smilagenin und anzurogenin-d zur behandlung der alzheimerischen krankheit
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
JP3370610B2 (ja) * 1998-08-21 2003-01-27 武田薬品工業株式会社 害虫防除剤
US20030060425A1 (en) * 1998-11-24 2003-03-27 Ahlem Clarence N. Immune modulation method using steroid compounds
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6343258B1 (en) 1999-08-13 2002-01-29 ALEXIS Brian Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
AU1122301A (en) * 1999-11-01 2001-05-14 Forbes Medi-Tech Inc. Novel glycosides comprising pentose mono-, di-, tri-, or oligosaccharides and phytosterols and/or phytostanols
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
US6207638B1 (en) 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
US6429190B1 (en) 2000-12-15 2002-08-06 Pacifichealth Laboratories, Inc. Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK)
WO2002047614A2 (en) 2000-12-15 2002-06-20 Pacific Health Laboratories, Inc. Nutritional composition for improving the efficacy of a lipase inhibitor
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
US6703530B2 (en) * 2002-02-28 2004-03-09 General Electric Company Chemical reactor system and process
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
KR101092150B1 (ko) * 2002-10-28 2011-12-12 파이토팜 피엘씨 사포겐-3-온의 입체특이적 환원
CA2590533C (en) 2004-11-23 2010-09-07 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CN102066397B (zh) * 2008-04-18 2013-09-11 里亚塔医药公司 包含抗炎症药效团的化合物以及使用方法
EP2309860B1 (en) * 2008-07-22 2014-01-08 Trustees of Dartmouth College Monocyclic cyanoenones and methods of use thereof
EP2571860A1 (en) 2010-05-21 2013-03-27 Pfizer Inc 2-phenyl benzoylamides
EP2680874A2 (en) 2011-03-04 2014-01-08 Pfizer Inc Edn3-like peptides and uses thereof
CU20110244A7 (es) * 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178418A (en) 1963-02-26 1965-04-13 Glaxo Lab Ltd Monobromination at the 11-position of hecogenin and 3-lower alkanoyl esters thereof
DE2926463A1 (de) * 1978-07-05 1980-01-24 Roecar Holdings Nv Spiroketaline und ihre verwendung
US4260603A (en) * 1979-01-02 1981-04-07 Pegel Karl H Sterol glycoside with activity as prostaglandin synthetase inhibitor
NZ193564A (en) * 1979-05-02 1985-01-31 Aruba Pty Ltd Steroid alkaloids from solanum sodomeum and pharmaceutical compositions
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
ES524614A0 (es) * 1982-08-12 1984-05-01 Nativelle Sa Ets Procedimiento de preparacion de nuevos amino-14 esteroides.
ES524796A0 (es) * 1982-08-20 1984-05-01 Nativelle Sa Ets Procedimiento de preparacion de nuevos derivos de amino-14 esteroides
IT1188184B (it) 1985-08-14 1988-01-07 Texcontor Ets Sali ammonici quaternari di polisaccaridi ad attivita' ipocolesterolemizzante
US5017562A (en) * 1987-02-11 1991-05-21 Regents Of The University Of Minnesota Crystalline saponin-containing complex
FR2621316B1 (fr) * 1987-10-02 1991-06-21 Nativelle Sa Ets Nouveaux esters d'acide androstane 17-carboxylique, procede pour leur preparation, et medicament les contenant
US5010185A (en) * 1989-06-13 1991-04-23 Pfizer Inc. Processes for tigogenin beta-cellobioside
EP0524595A1 (en) * 1991-07-23 1993-01-27 Schering Corporation Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
AU2675092A (en) * 1991-09-27 1993-04-27 Procter & Gamble Pharmaceuticals, Inc. Use of 14-aminosteroids for the manufacture of a medicament to slow the rate of progression of myocardial structural damages characteristic of congestive heart failure
DE69225233T2 (de) * 1991-10-04 1998-11-19 Procter & Gamble Cholesterinsenkende Verbindungen und Verfahren zu ihrer Herstellung
JPH0826064B2 (ja) * 1991-11-25 1996-03-13 ファイザー インク． ステロイドペルアシルグリコシド類の製法
US5530107A (en) * 1992-10-15 1996-06-25 Pfizer Inc. Method for making steroidal peracyl glycosides
LT3595B (en) * 1993-01-21 1995-12-27 Schering Corp Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents

Also Published As

Publication number Publication date
HRP930994A2 (en) 1996-08-31
CN1085561A (zh) 1994-04-20
IL106055A0 (en) 1993-10-20
MX9303826A (es) 1994-02-28
EP0796863A2 (en) 1997-09-24
CA2139104A1 (en) 1994-01-06
US5629295A (en) 1997-05-13
BR9306619A (pt) 1998-12-08
JPH07504921A (ja) 1995-06-01
US5703052A (en) 1997-12-30
RU94046294A (ru) 1996-10-10
BG99261A (en) 1995-06-30
WO1994000480A1 (en) 1994-01-06
SK158394A3 (en) 1995-05-10
EP0647234A1 (en) 1995-04-12
EP0796862A2 (en) 1997-09-24
CZ331094A3 (en) 1995-09-13
YU44793A (sh) 1996-10-09
AU4226593A (en) 1994-01-24
AP489A (en) 1996-05-02
AP9300539A0 (en) 1993-07-31
OA10121A (en) 1996-12-18
EP0796864A2 (en) 1997-09-24
JPH09309897A (ja) 1997-12-02

Similar Documents

Publication Publication Date Title
KR950702203A (ko) 콜레스테롤과잉혈증 치료용 스테로이드성 글리코사이드(steroldal glycosides for treating hypercholesterolemia)
FI931736A (fi) Biodegraderbart tgf-b-leveranssystem foer benregeneration
DE69120096T2 (de) Behandelte Papiere
DK0660689T3 (da) Osteosyntesehjælpemiddel
BR9306304A (pt) Absorvente feminino
NO933799D0 (no) Anti-ekstruderings-tetningsanordning
FI934735A (fi) Formpanel
DE69024596T2 (de) Ultraviolett-Abschirmmischungen
DE69328524T2 (de) Exonuklease-Dekontaminierungsverfahren
FI951163A0 (fi) Jätteen käsittely
KR950703689A (ko) 시일드 굴삭기(Shield cxcavator)
NO930233L (no) Fremgangsmaate ved hydratisering
DE69221873D1 (de) Magnetron
KR950700084A (ko) 소양증 치료제(antipruritic)
NO922087L (no) Anordning ved snurpering
KR950702184A (ko) 페닐티오메틸피리디닐알케노에이트의 제조방법(Process for making phenylthi omethypyridinylalkenoates)
ITMI931704A1 (it) Procedimento per trattare biancheria
BR9307085A (pt) Absorvente feminino
HU9201293D0 (en) Glass treating substance
NO922831D0 (no) Holdeboeyle for baater
NO924609D0 (no) Anodemantel for soederberganode
DE69325798D1 (de) Alkoxylierungsverfahren
NO924537D0 (no) Styrbar meie
LV10237A (lv) Arstniecibas lidzekli
BR7200582U (pt) Talisma astrologico

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application